跳至主要内容
临床试验/NCT03856476
NCT03856476已完成不适用

Early Markers of Endothelial and Renal Dysfunction in Children With Dyslipidemia

University of Ioannina1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2017年4月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
1
主要终点
Flow-mediated dilation of the branchial artery

研究概览

简要总结

The aim of the study is to assess if abnormal lipid levels in childhood could cause early damage of the inner layer of the vessels, the endothelium. Dysfunction of the endothelium is the first event in the development of atherosclerosis, is present at all stages of atherosclerosis and is potentially reversible in childhood. It has been suggested that dyslipidemia, via its detrimental effects on endothelium, could impair renal function. This study will assess the dysfunction of the kidneys in children with dyslipidemia.

详细描述

In children recruited in the study, family history of dyslipidemia or premature cardiovascular disease will be recorded. Furthermore, anthropometric and clinical characteristics will be noted and lipid measurements will be obtained at recruitment after a fasting period.

The investigators will test in children the flow-mediated dilation (FMD) which assesses the vasodilation due to the production of nitric oxide from the endothelium in response to occlusion-induced hyperaemia of the branchial artery and the carotid intima-media thickness (cIMT). These non-invasive ultrasound indices detect early vascular damage.

Renal function will be assessed in children with dyslipidemia by a new marker in serum, cystatin C, which is more accurate and reliable than creatinine. Also, creatinine serum levels and estimated glomerular filtration rate (eGFR) will be evaluated. Additionally, total protein, albumin, electrolyte and β2-microglobulin excretion in urine will be measured.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
7 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children and adolescents aged 7 to 17 years
  • Dyslipidemia (serum levels of LDL-cholesterol ≥95th percentile or serum levels of triglycerides ≥95th percentile or serum levels of HDL-cholesterol ≤5th percentile for age and sex)

排除标准

  • History of renal disease
  • Dyslipidemia caused by nephrotic syndrome or chronic kidney disease
  • Chronic use of medication
  • Acute or chronic inflammatory process

结局指标

主要结局

Flow-mediated dilation of the branchial artery

时间窗: At subject enrollment

Non-invasive ultrasound assessment of endothelial function.

Carotid intima-media thickness

时间窗: At subject enrollment

Non-invasive ultrasound assessment of early vascular disease.

Measurement of cystatin C in serum

时间窗: At subject enrollment

Cystatin C is a marker for assessing renal function

次要结局

  • Assessment of eGFR(At subject enrollment)
  • Number of participants with abnormal levels of lipoprotein a.(At subject enrollment)
  • Levels of β2-microglobulin in urine(At subject enrollment)
  • Serum creatinine levels(At subject enrollment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chrysoula Kosmeri

Principal Investigator

University of Ioannina

研究点 (1)

Loading locations...

相似试验